The motion is as follows:
That members of the Committee be given a period of one week to review the report entitled Prescription Drugs Part 1 - Common Drug Review, previously adopted by the Committee in the First Session, 39th Parliament on June 13, 2007; and that the matter of the adoption of the report in the current session, and its presentation in the House, be taken up at the next scheduled Committee meeting following the one week review period.
I've tabled this motion for discussion before the health committee in regard to the report of the study of the CDR, and I want to explain why.
First, let me assure you that the only reason I've tabled the motion is because basically half the health committee is new. Second, I feel that it's fair for all of us, including my opposition colleagues, to have one week to review the report in its entirety so the new health committee can table it. Third, I'm not indicating one way or the other if I want any changes made; I only want the opportunity to review the report and its recommendations. I want you guys to have the opportunity to review the report and its recommendations before tabling, especially as it's been a number of months since we last looked at the CDR draft.
I recognize the hard work that members have put into the report, and feel that our new members should have the opportunity to review it before commenting and putting their names to it.
Previous members of the health committee, including our chair, Mr. Merrifield, Rahim Jaffer, and the opposition members who are no longer with us, put a lot of work into this, and that should be recognized.